Comparative study of Chinese hamster ovary cell versus escherichia coli-derived bone morphogenetic protein-2 using the critical-size supraalveolar peri-implant defect model

Jaebum Lee, Eui Nam Lee, James Yoon, Sung Min Chung, Hari Prasad, Cristiano Susin, Ulf M E Wikesjö

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Chinese hamster ovary (CHO) cell-derived recombinant human bone morphogenetic protein-2 (rhBMP-2) has been introduced for spine, long bone, and craniofacial indications. Escherichia coli- (E. coli) derived rhBMP-2 displays comparable efficacy to CHO cell-derived rhBMP-2 in vitro and in small-animal models. The objective of this study is to evaluate the efficacy of E. coli-derived rhBMP-2 compared to the benchmark CHO cell-derived rhBMP-2 using an established large-animal model. Methods: Contralateral, critical-size supraalveolar peri-implant defects in six adult male Hound Labrador mongrel dogs received CHOcell- or E. coli-derived rhBMP-2 (0.2 mg/mL) in an absorbable collagen sponge (ACS) carrier. In each quadrant, three dental implants were placed. A titaniummesh device was used to support space provision. The animals received fluorescent bone markers for qualitative evaluations. Animals were euthanized at 8 weeks for histopathologic and histometric evaluation. Results: Clinical healing included significant swelling, but none of the animals experienced wound dehiscences. CHO cell- and E. coli-derived rhBMP-2 supported comparable bone formation (new bone area, 35.8 ± 3.6 versus 30.1 ± 2.2 mm2; bone density, 31.8% ± 1.6% versus 35.6% ± 2.5%; and osseointegration, 32.9% ± 7.4% versus 33.7% ± 8.1%) without statistically significant differences between treatments. Newly formed immature delicate trabecular bone in fibrovascular marrow filled the space underneath the titanium mesh and extended coronally above the mesh. Seroma formation was frequently observed. There were no discernable qualitative histologic differences between treatments. Conclusion: CHO cell- and E. coli-derived rhBMP-2 in an ACS carrier appear equally effective at inducing local bone formation in support of dental implant osseointegration.

Original languageEnglish (US)
Pages (from-to)415-422
Number of pages8
JournalJournal of periodontology
Volume84
Issue number3
DOIs
StatePublished - Mar 1 2013

Fingerprint

Escherichia
Bone Morphogenetic Protein 2
Cricetulus
Ovary
Escherichia coli
Osseointegration
Dental Implants
Porifera
Osteogenesis
Bone and Bones
Collagen
Animal Models
Newfoundland and Labrador
Seroma
Benchmarking
recombinant human bone morphogenetic protein-2
Titanium
Bone Density
Spine
Bone Marrow

Keywords

  • Alveolar ridge augmentation
  • Bone morphogenetic protein 2
  • CHO cells
  • Dental implants
  • Escherichia coli
  • Growth differentiation factors

ASJC Scopus subject areas

  • Periodontics

Cite this

Comparative study of Chinese hamster ovary cell versus escherichia coli-derived bone morphogenetic protein-2 using the critical-size supraalveolar peri-implant defect model. / Lee, Jaebum; Lee, Eui Nam; Yoon, James; Chung, Sung Min; Prasad, Hari; Susin, Cristiano; Wikesjö, Ulf M E.

In: Journal of periodontology, Vol. 84, No. 3, 01.03.2013, p. 415-422.

Research output: Contribution to journalArticle

Lee, Jaebum ; Lee, Eui Nam ; Yoon, James ; Chung, Sung Min ; Prasad, Hari ; Susin, Cristiano ; Wikesjö, Ulf M E. / Comparative study of Chinese hamster ovary cell versus escherichia coli-derived bone morphogenetic protein-2 using the critical-size supraalveolar peri-implant defect model. In: Journal of periodontology. 2013 ; Vol. 84, No. 3. pp. 415-422.
@article{3bd4efc813084e3c937bbec0dcd0673f,
title = "Comparative study of Chinese hamster ovary cell versus escherichia coli-derived bone morphogenetic protein-2 using the critical-size supraalveolar peri-implant defect model",
abstract = "Background: Chinese hamster ovary (CHO) cell-derived recombinant human bone morphogenetic protein-2 (rhBMP-2) has been introduced for spine, long bone, and craniofacial indications. Escherichia coli- (E. coli) derived rhBMP-2 displays comparable efficacy to CHO cell-derived rhBMP-2 in vitro and in small-animal models. The objective of this study is to evaluate the efficacy of E. coli-derived rhBMP-2 compared to the benchmark CHO cell-derived rhBMP-2 using an established large-animal model. Methods: Contralateral, critical-size supraalveolar peri-implant defects in six adult male Hound Labrador mongrel dogs received CHOcell- or E. coli-derived rhBMP-2 (0.2 mg/mL) in an absorbable collagen sponge (ACS) carrier. In each quadrant, three dental implants were placed. A titaniummesh device was used to support space provision. The animals received fluorescent bone markers for qualitative evaluations. Animals were euthanized at 8 weeks for histopathologic and histometric evaluation. Results: Clinical healing included significant swelling, but none of the animals experienced wound dehiscences. CHO cell- and E. coli-derived rhBMP-2 supported comparable bone formation (new bone area, 35.8 ± 3.6 versus 30.1 ± 2.2 mm2; bone density, 31.8{\%} ± 1.6{\%} versus 35.6{\%} ± 2.5{\%}; and osseointegration, 32.9{\%} ± 7.4{\%} versus 33.7{\%} ± 8.1{\%}) without statistically significant differences between treatments. Newly formed immature delicate trabecular bone in fibrovascular marrow filled the space underneath the titanium mesh and extended coronally above the mesh. Seroma formation was frequently observed. There were no discernable qualitative histologic differences between treatments. Conclusion: CHO cell- and E. coli-derived rhBMP-2 in an ACS carrier appear equally effective at inducing local bone formation in support of dental implant osseointegration.",
keywords = "Alveolar ridge augmentation, Bone morphogenetic protein 2, CHO cells, Dental implants, Escherichia coli, Growth differentiation factors",
author = "Jaebum Lee and Lee, {Eui Nam} and James Yoon and Chung, {Sung Min} and Hari Prasad and Cristiano Susin and Wikesj{\"o}, {Ulf M E}",
year = "2013",
month = "3",
day = "1",
doi = "10.1902/jop.2012.110369",
language = "English (US)",
volume = "84",
pages = "415--422",
journal = "Journal of Periodontology",
issn = "0022-3492",
publisher = "American Academy of Periodontology",
number = "3",

}

TY - JOUR

T1 - Comparative study of Chinese hamster ovary cell versus escherichia coli-derived bone morphogenetic protein-2 using the critical-size supraalveolar peri-implant defect model

AU - Lee, Jaebum

AU - Lee, Eui Nam

AU - Yoon, James

AU - Chung, Sung Min

AU - Prasad, Hari

AU - Susin, Cristiano

AU - Wikesjö, Ulf M E

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Background: Chinese hamster ovary (CHO) cell-derived recombinant human bone morphogenetic protein-2 (rhBMP-2) has been introduced for spine, long bone, and craniofacial indications. Escherichia coli- (E. coli) derived rhBMP-2 displays comparable efficacy to CHO cell-derived rhBMP-2 in vitro and in small-animal models. The objective of this study is to evaluate the efficacy of E. coli-derived rhBMP-2 compared to the benchmark CHO cell-derived rhBMP-2 using an established large-animal model. Methods: Contralateral, critical-size supraalveolar peri-implant defects in six adult male Hound Labrador mongrel dogs received CHOcell- or E. coli-derived rhBMP-2 (0.2 mg/mL) in an absorbable collagen sponge (ACS) carrier. In each quadrant, three dental implants were placed. A titaniummesh device was used to support space provision. The animals received fluorescent bone markers for qualitative evaluations. Animals were euthanized at 8 weeks for histopathologic and histometric evaluation. Results: Clinical healing included significant swelling, but none of the animals experienced wound dehiscences. CHO cell- and E. coli-derived rhBMP-2 supported comparable bone formation (new bone area, 35.8 ± 3.6 versus 30.1 ± 2.2 mm2; bone density, 31.8% ± 1.6% versus 35.6% ± 2.5%; and osseointegration, 32.9% ± 7.4% versus 33.7% ± 8.1%) without statistically significant differences between treatments. Newly formed immature delicate trabecular bone in fibrovascular marrow filled the space underneath the titanium mesh and extended coronally above the mesh. Seroma formation was frequently observed. There were no discernable qualitative histologic differences between treatments. Conclusion: CHO cell- and E. coli-derived rhBMP-2 in an ACS carrier appear equally effective at inducing local bone formation in support of dental implant osseointegration.

AB - Background: Chinese hamster ovary (CHO) cell-derived recombinant human bone morphogenetic protein-2 (rhBMP-2) has been introduced for spine, long bone, and craniofacial indications. Escherichia coli- (E. coli) derived rhBMP-2 displays comparable efficacy to CHO cell-derived rhBMP-2 in vitro and in small-animal models. The objective of this study is to evaluate the efficacy of E. coli-derived rhBMP-2 compared to the benchmark CHO cell-derived rhBMP-2 using an established large-animal model. Methods: Contralateral, critical-size supraalveolar peri-implant defects in six adult male Hound Labrador mongrel dogs received CHOcell- or E. coli-derived rhBMP-2 (0.2 mg/mL) in an absorbable collagen sponge (ACS) carrier. In each quadrant, three dental implants were placed. A titaniummesh device was used to support space provision. The animals received fluorescent bone markers for qualitative evaluations. Animals were euthanized at 8 weeks for histopathologic and histometric evaluation. Results: Clinical healing included significant swelling, but none of the animals experienced wound dehiscences. CHO cell- and E. coli-derived rhBMP-2 supported comparable bone formation (new bone area, 35.8 ± 3.6 versus 30.1 ± 2.2 mm2; bone density, 31.8% ± 1.6% versus 35.6% ± 2.5%; and osseointegration, 32.9% ± 7.4% versus 33.7% ± 8.1%) without statistically significant differences between treatments. Newly formed immature delicate trabecular bone in fibrovascular marrow filled the space underneath the titanium mesh and extended coronally above the mesh. Seroma formation was frequently observed. There were no discernable qualitative histologic differences between treatments. Conclusion: CHO cell- and E. coli-derived rhBMP-2 in an ACS carrier appear equally effective at inducing local bone formation in support of dental implant osseointegration.

KW - Alveolar ridge augmentation

KW - Bone morphogenetic protein 2

KW - CHO cells

KW - Dental implants

KW - Escherichia coli

KW - Growth differentiation factors

UR - http://www.scopus.com/inward/record.url?scp=84874614050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874614050&partnerID=8YFLogxK

U2 - 10.1902/jop.2012.110369

DO - 10.1902/jop.2012.110369

M3 - Article

C2 - 22612368

AN - SCOPUS:84874614050

VL - 84

SP - 415

EP - 422

JO - Journal of Periodontology

JF - Journal of Periodontology

SN - 0022-3492

IS - 3

ER -